|
| Press Releases |
|
 |
|
| Tuesday, July 26, 2022 |
|
|
노보텍의 유연 근무 정책, 최고 유연 근무 프로그램의 ‘2022년 우수상’ 최종 후보로 선정 |
| 미국으로 서비스를 확장한, 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 유연 근무에 대한 자사의 혁신적인 접근 방식을 인정받았다. more info >> |
|
| Monday, July 25, 2022 |
|
|
Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖” |
| Novotech 是亚太地区领先的生物技术临床研究机构，近期入驻美国，因其创新的工作场所灵活性方法而获得认可。 more info >> |
|
|
Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎” |
| Novotech 是亞太地區領先的生物技術臨床研究機構，近期入駐美國，因其創新的工作場所靈活性方法而獲得認可。 more info >> |
|
|
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022" |
| Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative approach to workplace flexibility. more info >> |
|
| Tuesday, July 19, 2022 |
|
|
노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표 |
| 미국으로 서비스를 확장한, 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 ‘현 상황과 미래의 기회’란 주제로 중국의 CAR-T 치료법에 관한 엔드포인트 웨비나를 진행할 예정이다. more info >> |
|
|
Novotech和Endpoints展示“中国细胞和基因治疗的演变：通用CAR-T的案例” |
| Novotech 是亚太地区领先的生物技术专家 CRO，在美国提供扩展服务，很高兴在中国举办一场关于 CAR-T 治疗的 Endpoints 网络研讨会——当前形势和未来机遇。 more info >> |
|
|
Novotech和Endpoints展示“中國細胞和基因治療的演變：通用CAR-T的案例” |
| Novotech 是亞太地區領先的生物技術專家 CRO，在美國提供擴展服務，很高興在中國舉辦一場關於 CAR-T 治療的 Endpoints 網絡研討會——當前形勢和未來機遇。 more info >> |
|
| Monday, July 18, 2022 |
|
|
Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T" |
| Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, is pleased to present an Endpoints webinar on CAR-T therapy in China - the current landscape and future opportunities. more info >> |
|
| Thursday, July 14, 2022 |
|
|
노보텍 고객사 SK바이오사이언스, 스카이코비원(SKYCovione(TM)) 코로나19 백신 국내 승인 |
| 최근 미국으로 서비스를 확장한, 아시아 태평양 지역 바이오테크 전문 임상 시험수탁기관(CRO)인 노보텍(Novotech)은 고객사인 SK바이오사이언스의 코로나19 백신이 품목허가를 승인 받은 것을 축하했다. more info >> |
|
|
Novotech 客户 SK bioscience 在韩国获得 SKYCovione(TM) COVID-19 疫苗批准 |
| Novotech是亚太地区领先的生物技术临床研究机构，近期入驻美国，祝贺其客户 SK bioscience 最近获得 COVID-19疫苗许可。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
LEXUS、モントレー・カー・ウィーク2022でNEXT CHAPTERモデルを出展
Aug 19, 2022 16:00: JST
|
|
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT/SGT
|
|
|
台灣精品於 2022 年新加坡國際醫療展首次亮相 展出10 家醫療科技暨照護領域的創新企業
Aug 19, 2022 14:01 HKT/SGT
|
|
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT/SGT
|
|
|
Taiwan Excellence Pavilion to showcase 10 leading medical tech innovators at Medical Fair Asia 2022
Aug 19, 2022 14:00 HKT/SGT
|
|
|
港股稀缺标的百奥赛图今日开启招股
Aug 19, 2022 11:41 HKT/SGT
|
|
|
港股稀缺標的百奧賽圖今日開啟招股
Aug 19, 2022 11:40 HKT/SGT
|
|
|
Sirnaomics核心产品RNAi治疗药物STP705用于治疗面部原位鳞状细胞皮肤癌的I/II期临床试验完成首例受试者给药
Aug 19, 2022 11:32 HKT/SGT
|
|
|
Sirnaomics核心產品RNAi治療藥物STP705用於治療面部原位鱗狀細胞皮膚癌的I/II期臨床試驗完成首例受試者給藥
Aug 19, 2022 11:31 HKT/SGT
|
|
|
Sirnaomics Doses the First Patient in Phase I/II Clinical Study of RNAi Therapeutic STP705 for Treatment of Facial Squamous Cell Skin Cancer In Situ
Aug 19, 2022 11:30 HKT/SGT
|
|
|
顺丰同城H股全流通申请获中国证监会正式批准 业内：有利于改善流动性和成交量
Aug 19, 2022 10:32 HKT/SGT
|
|
|
順豐同城H股全流通申請獲中國證監會正式批准 業內：有利於改善流動性和成交量
Aug 19, 2022 10:31 HKT/SGT
|
|
|
After 500 per cent spike in a single day, MuskMelon NFT advances its game for yielding higher returns
Aug 19, 2022 09:00: JST
|
|
|
After 500 per cent spike in a single day, MuskMelon NFT advances its game for yielding higher returns
Aug 19, 2022 08:00 HKT/SGT
|
|
|
CTG DUTY-FREE HK Public Offering Has Been Fully Applied with High Multiple Order Coverage From International Placing
Aug 18, 2022 19:58 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
